Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease

NCT01215890 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Crohn's Disease
Low Bone Mineral Density

Interventions

DRUG: risedronate
DRUG: placebo

Sponsor

University of Alberta